Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Recurrent Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389239
What this trial is testing

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

Who this might be right for
Ovarian CancerAdvanced Malignant Solid Tumor
University of Chicago 24
Testing effectiveness (Phase 2)Study completedNCT00003939
What this trial is testing

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more
European Organisation for Research and Treatment of Cancer - EORTC 132
Testing effectiveness (Phase 2)UnknownNCT00003718
What this trial is testing

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerOvarian CancerSarcoma
Herbert Irving Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT04015739
What this trial is testing

Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse

Who this might be right for
Epithelial Ovarian CancerRelapse
ARCAGY/ GINECO GROUP 74
Testing effectiveness (Phase 2)Looking for participantsNCT06843447
What this trial is testing

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Who this might be right for
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLC 605
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339553
What this trial is testing

Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.

Who this might be right for
OvariancancerPlatinum-sensitive Recurrent
Peking University Third Hospital 30
Early research (Phase 1)Study completedNCT00410553
What this trial is testing

Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmRecurrent Ovarian CarcinomaRecurrent Uterine Corpus Carcinoma+4 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00002526
What this trial is testing

Chemotherapy in Treating Patients With Advanced Sarcoma

Who this might be right for
Ovarian CancerSarcoma
Swiss Cancer Institute 20
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Very early researchStudy completedNCT02111941
What this trial is testing

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more
Mayo Clinic 19
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00070096
What this trial is testing

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT00002487
What this trial is testing

Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Ottawa Regional Cancer Centre
Early research (Phase 1)WithdrawnNCT02117817
What this trial is testing

Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer

Who this might be right for
Ovarian CancerEndometrial CancerRecurrent Ovarian Cancer+1 more
Rutgers, The State University of New Jersey
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Large-scale testing (Phase 3)Not Yet RecruitingNCT07286162
What this trial is testing

Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer (OvCa)Recurrent Ovarian Cancer
University Health Network, Toronto 300
Early research (Phase 1)Ended earlyNCT03608618
What this trial is testing

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Who this might be right for
Peritoneal MesotheliomaFallopian Tube AdenocarcinomaAdenocarcinoma of the Ovary+1 more
MaxCyte, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT00019084
What this trial is testing

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerCervical CancerColorectal Cancer+3 more
National Cancer Institute (NCI)
Next Page